TABLE 3.

General and clinical features of the study population

Gender
Male	27 (37.5%)
Female	45 (62.5%)
Age (years)	49.2 ± 13.7 (Range 26‐90)
Days from COVID‐19 symptoms onset	19.3 ± 4.5 (Range 7‐27)
Days from positive swab	15.6 ± 4.3 (Range 5‐26)
Referred symptoms
Fever	69 (95.8%)
Cough	60 (83.3%)
Nasal obstruction	11 (15.3%)
Rhinorrhea	13 (18.1%)
Sore throat	37 (51.4%)
Headache	30 (41.6%)
Asthenia	48 (66.7%)
Abdominal symptoms	8 (11.1%)
Pneumonia	22 (30.6%)
Referred chemosensory dysfunctions
Olfactory and taste disorders	30 (41.7%)
Only olfactory disorders	14 (14.4%)
Only taste disorders	9 (12.5%)
Total	53 (73.6%)
No taste or olfactory disorders	19 (26.4%)
Chemosensory subjective complete recovery (patients no 53)
Yes	35 (66%)
In <5 days	19 (35.8%)
In >5 days	16 (30.2%)
No	18 (34%)